Smart Insulin Pen Market to Reach a Market Size of $117.3 Million by 2024 - KBV Research

News provided by

KBV Research

21 Feb, 2019, 20:30 IST

NEW DELHI, Feb. 21, 2019 /PRNewswire/ -- According to a new report Global Smart Insulin Pen Market, published by KBV research, The Global Smart Insulin Pen Market size is expected to reach $117.3 Million by 2024, rising at a market growth of 10.2% CAGR during the forecast period. The demand is due to rapidly rising number of diabetic patients, and cost-effectiveness of the smart insulin pens. In addition, the simple functioning and accurate delivery of appropriate dosing adds to the demand.

The North America market would dominate the Global Second Generation Pens Market by Region in by 2024, growing at a CAGR of 9.7 % during the forecast period. The Europe market is expected to witness a CAGR of 10.2% during (2018 - 2024). Additionally, The Asia Pacific market is expected to witness a CAGR of 11.9% during (2018 - 2024). Asia Pacific would be the fastest growing market, which offers lucrative opportunities for the market growth, due to its substantial population base and growing diabetic patients. On the other hand, affordability of the Insulin pens also propels the market growth in the region.

The Hospitals & Clinics market dominated the Global Smart Insulin Pen Market by End User in 2017. The Ambulatory Surgical Centers market is expected to witness a CAGR of 10.6% during (2018 - 2024). The major factors that drive the growth of the market include growing diabetic population, lower cost of insulin pumps, and painless injections.

Access Full Report: https://www.kbvresearch.com/smart-insulin-pen-market/

The Prefilled market dominated the Global Smart Insulin Pen Market by Usability in 2017, and would achieve a market value of $64,759.4 Thousand by 2024. The Reusable market is expected to witness a CAGR of 10.7% during (2018 - 2024).

The market research report has exhaustive quantitative insights providing a clear picture of the market potential in various segments across the globe with country wise analysis in each discussed region. The key impacting factors of the market have been discussed in the report with the elaborated company profiles of Companion Medical Inc., Digital Medics Ptd Ltd., Eli Lilly and Company, Novo Nordisk A/S, Diamesco Co., Ltd., F. Hoffmann-La Roche AG, Insulet Corporation, Emperra GmbH E-Health Technologies, Jiangsu Delfu medical device Co. Ltd., Bigfoot Biomedical.

Global Smart Insulin Pen Market Segmentation

By Product 

  • Second Generation Pens
    o   USB Connected Smart Insulin Pen
    o   Bluetooth-Enabled Smart Insulin Pen
  • First Generation Pens

By Usability

  • Prefilled
  • Reusable

By End User

  • Hospitals & Clinics
  • Ambulatory Surgical Centers
  • Home care settings

 By Geography

  • North America
    o   US
    o   Canada
    o   Mexico
    o   Rest of North America 
  • Europe
    o   Germany
    o   UK
    o   France
    o   Russia
    o   Spain
    o   Italy
    o   Rest of Europe 
  • Asia Pacific
    o   China
    o   Japan
    o   India
    o   South Korea
    o   Singapore
    o   Malaysia
    o   Rest of Asia Pacific 
  • LAMEA
    o   Brazil
    o   Argentina
    o   UAE
    o   Saudi Arabia
    o   South Africa
    o   Nigeria
    o   Rest of LAMEA

Companies Profiled

  • Companion Medical Inc.
  • Digital Medics Ptd Ltd.
  • Eli Lilly and Company
  • Novo Nordisk A/S
  • Diamesco Co., Ltd.
  • F. Hoffmann-La Roche AG
  • Insulet Corporation
  • Emperra GmbH E-Health Technologies
  • Jiangsu Delfu medical device Co. Ltd.
  • Bigfoot Biomedical

Unique Offerings from KBV Research

  • Exhaustive coverage  
  • Highest number of market tables and figures
  • Subscription based model available
  • Guaranteed best price
  • Assured post sales research support with 10% customization free

Related Reports:

About Us:

Knowledge Based Value Research is a global brand and consulting firm serving all kinds of business verticals, government and non-governmental organizations, and not-for-profit organizations. Our motto is to extend our services that will have a lasting impact on our clients who trust us with their business goals.

Our aim is to transform and customize our services to address the fast changing business needs of our clients. With innovative methods, we seek to empower our research tools with new capabilities that would eventually bring about customer delight, as we understand that businesses evolve.

Media Contact:

Mr. Alan D'Souza
KBV Research
244 Fifth Avenue, Suite 1407
New York, N.Y. 10001
United States (U.S)
Tel: +1 (646) 661-6066
Email: [email protected]